Mechanisms Associated with PINK1 Variants in Parkinson's Disease
F1000Research · 18.06.2026 · 14 · 1138
DOI: 10.12688/f1000research.170090.3 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift F1000Research, online erschienen am 18.06.2026. Verfasst von Hanliang Dan und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Biology, Faculty of Applied Sciences, Universiti Teknologi MARA, UiTM, Shah Alam Seksyen 2, 40450 Selangor, Malaysia. Hauptthemen laut MEDLINE: Parkinson Disease, Protein Kinases. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Parkinson’s disease (PD) is a widespread and progressively debilitating neurodegenerative disorder with a growing global prevalence. While most cases are sporadic, loss-of-function variants in the PINK1 gene are a primary cause of autosomal recessive early-onset PD. This review critically explores the molecular mechanisms linking PINK1 dysfunction to PD, with a specific focus on the kinase’s role in phosphorylating Ubiquitin and Parkin at the conserved Serine 65 (Ser65) residue. We discuss how this phosphorylation event acts as a molecular switch to recruit the novel autophagy receptors Optineurin (OPTN) and NDP52, thereby initiating mitophagy—a process often disrupted by pathogenic variants. Furthermore, we examine the emerging role of PINK1 in suppressing neuroinflammation via the STING pathway and evaluate the translational potential of targeting these molecular checkpoints for therapeutic intervention. These insights lay the groundwork for developing precision medicine strategies to address the urgent need for effective PD treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biology, Faculty of Applied Sciences, Universiti Teknologi MARA, UiTM, Shah Alam Seksyen 2, 40450 Selangor, Malaysia.
- Centre for Chemical Synthesis and Polymer Technology, Institute of Science, Universiti Teknologi MARA, UiTM, Shah Alam Seksyen 2, 40450 Selangor, Malaysia.
- Nanxishan Hospital of Guangxi Zhuang Autonomous Region (The Second People's Hospital of Guangxi Zhuang Autonomous Region), Guilin, Guangxi 541002, China.
- Guangxi Key Laboratory of Multimodal Biomarkers and Precision Diagnosis, College of Medical Laboratory and Biotechnology, Guilin Medical University, Guilin, Guangxi, 541004, China.
- Guilin Medical University, Guangxi Key Laboratory of Tumor Immunology and Microenvironment Regulation, Department of Basic Medicine, Guilin, Guangxi 541004, China.
ORCID-Profile: Hanliang Dan, Zheng Liu
Zitieren
APA
Dan, H., Huang, X., Liu, Z., Wei, B., & Musa, M. (2026). Mechanisms Associated with PINK1 Variants in Parkinson's Disease. F1000Research, 14, 1138. https://doi.org/10.12688/f1000research.170090.3
Vancouver
Dan H, Huang X, Liu Z, Wei B, Musa M. Mechanisms Associated with PINK1 Variants in Parkinson's Disease. F1000Research. 2026;14:1138. doi:10.12688/f1000research.170090.3
BibTeX
@article{Dan2026,
author = {Dan, Hanliang and Huang, Xiaohui and Liu, Zheng and Wei, Bing and Musa, Maslinda},
title = {Mechanisms Associated with PINK1 Variants in Parkinson's Disease},
journal = {F1000Research},
year = {2026},
volume = {14},
pages = {1138},
doi = {10.12688/f1000research.170090.3}
}
EUVIMED